RxDoctor Payments Data

Sonam Cogdill

Physician Assistant · Manning, SCNPI 1205440955

Payments from drug & device makers

$893in general payments, 2019–2025

Across 51 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$208
  • AstraZeneca$204
  • Novo Nordisk$105
  • AbbVie$103
  • GSK$56
  • Merck$51
  • plus $166 from 8 others

What the payments were for

  • Food & beverage$893100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$893 in reported general payments places this provider in the 65th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$35,233
Medicare patients
172
Services billed
1,089

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide40$43,624
RybelsusSemaglutide34$37,367
JardianceEmpagliflozin34$33,104
JanuviaSitagliptin Phosphate37$30,776
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$22,602
VraylarCariprazine Hcl12$18,308
LinzessLinaclotide15$16,122
FarxigaDapagliflozin Propanediol24$13,843
Breo ElliptaFluticasone/Vilanterol27$11,729
EntrestoSacubitril/Valsartan12$10,704
JanumetSitagliptin Phos/Metformin Hcl12$10,266
Albuterol Sulfate HfaAlbuterol Sulfate99$2,525
Diclofenac Sodium69$2,264
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$1,704
Fluticasone Propionate139$1,689

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$105$80,99274 claims
MerckJanuvia, Janumet$51$41,04249 claims
AbbVieVraylar, Linzess$103$34,43027 claims
GSKTrelegy Ellipta, Breo Ellipta$56$34,33159 claims
Boehringer IngelheimJardiance$208$33,10434 claims
AstraZenecaFarxiga$204$13,84324 claims
NovartisEntresto$17$10,70412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Manning

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →